United States Court of Federal Claims, 2017

Barrantes-Vargas v. Secretary of Health and Human Services

United States Court of Federal Claims · Decided March 14, 2017 · Laura D Millman

Opinion

In the United States Court of Federal Claims

OFFICE OF SPECIAL MASTERS

No. 16-1515V

Filed: February 16, 2017 Not to be Published *************************************

CARLOS BARRANTES-VARGAS, * *

Petitioner, * Motion for voluntary dismissal; * Order Concluding Proceedings v. * under Vaccine Rule 21(a)(1)(A); * PPV/23 and flu vaccines; positive SECRETARY OF HEALTH * HLA-B27 marker spondyloarthropathy AND HUMAN SERVICES, * *

Respondent. * * *************************************

Kenneth W. Thayer, III, West Trenton, NJ, for petitioner.

Lisa A. Watts, Washington, DC, for respondent.

MILLMAN, Special Master

ORDER CONCLUDING PROCEEDINGS 1

On November 15, 2016, petitioner filed a petition under the National Childhood Vaccine Injury Act, 42 U.S.C. § 300aa-10-34 (2012), alleging that influenza (“flu”) and Pneumovax (PPV/23) vaccines administered on November 17, 2013 caused him positive HLA-B27 marker spondyloarthropathy. See Pet. Preamble.

On February 16, 2017, petitioner orally made a Motion for Voluntary Dismissal under Vaccine Rule 21(a)(1)(A).

DISCUSSION

Under Vaccine Rule 21(a)(1)(A), petitioner may engage in a voluntary dismissal by making a motion for dismissal at any time before service of respondent’s Rule 4(c) Report, which petitioner has done in the instant action.

Under Vaccine Rule 21(a)(3), the result of this voluntary dismissal is an Order Concluding Proceedings. No judgment will enter pursuant to Vaccine Rule 11 for purposes of U.S.C. § 300aa-21(a).

CONCLUSION

This petition is DISMISSED. The clerk of the court is directed to remove this case from the docket of the undersigned.

IT IS SO ORDERED.

Dated: February 16, 2017 s/ Laura D. Millman Laura D. Millman Special Master

1 Because this Order Concluding Proceedings contains a reasoned explanation for the special master’s action in this case, the special master intends to post this Order Concluding Proceedings on the United States Court of Federal Claims’ website, in accordance with the E-Government Act of 2002, 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government Services). Vaccine Rule 18(b) states that all decisions of the special masters will be made available to the public unless they contain trade secrets or commercial or financial information that is privileged and confidential, or medical or similar information whose disclosure would constitute a clearly unwarranted invasion of privacy. When such a decision is filed, petitioners have 14 days to identify and move to redact such information prior to the document’s disclosure. If the special master, upon review, agrees that the identified material fits within the categories listed above, the special master shall redact such material from public access.

Case-law data current through September 30, 2026. Source: CourtListener bulk data.